Pristine C 60 fullerenes inhibit the rate of tumor growth and metastasis

Experimental Oncology

Volumn 33, Issue 3, 2011, Pages 162-164

  Prylutska, S V ^a   Burlaka, A P ^b   Prylutskyy, Yu I ^a   Ritter, U ^c   Scharff, P ^c  

^a TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c ILMENAU UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Lewis lung carcinoma; Tumor growth; Water soluble pristine C 60 fullerenes

Indexed keywords

ANTINEOPLASTIC AGENT; C60 FULLERENE; FULLERENE DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SOLUBILITY; LEWIS CARCINOMA; LIFESPAN; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CELL PROLIFERATION; FULLERENES; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

EID: 80053390463     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Freitas Jr RA. Nanomedicine, Volume IIA: Biocompatibility. Georgetown, TX: Landes Bioscience, 2003.
2. Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes. Series: Carbon Materials: Chemistry and Physics. F. Cataldo, T. Da Ros (Eds.). Netherlands: Springer, 2008.
3. Anilkumar P, Lu F, Cao L, et al. Fullerenes for applications in biology and medicine. Current Med Chem 2011; 18: 2045-59.
4. 60 Fullerene Molecule Toxic?! Fullerenes, Nanotubes, and Carbon Nanostruct 2005; 13: 363-76.
5. 60 fullerenes: detection of intracellular photoluminescence and lack of cytotoxic effects. J Nanobiotechnol. 2006; 4: 4-14.
6. 60-containing composites cytotoxicity in vitro. Mater Sci Engineer C 2007; 27: 1121-4.
7. Johnston HJ, Hutchison GR, Christensen FM, et al. The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol Sci 2010; 114: 162-82.
8. Foley S, Crowley C, Smaihi M, et al. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002; 294: 116-9. (Pubitemid 34687223)
9. 60 fullerenes in vitro and in a model system. Mol Cryst Liq Cryst 2007; 468: 265-74.
10. 60 compound with a model bimolecular lipid membrane. Mater Sci Engineer C 2011; 31: 1148-50.
11. 60 fullerenes in vitro. Fullerenes, Nanotubes, Carbon Nanostruct 2008; 16: 698-705.
12. Murugesan S, Mousa SA, O'Connor LJ, et al. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett 2007; 581: 1157-60. (Pubitemid 46385938)
13. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6. (Pubitemid 43093958)
14. 60 fullerene in water: spectroscopic data. Carbon 2004; 42: 1203-6.
15. 60nanoparticles in water solution and on the support. Eur Phys J D 1999; 9: 341-3.
16. 60 in aqueous solution. Phys Chem Chem Phys 2000; 2: 1627-9.
17. 60 fullerenes on the hydrated properties of nanocomposites based on highly dispersed silica and DNA. Chem Phys Lett 2010; 496: 152-6.
18. 60 fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 2005; 5: 2578-85.
19. Gubler EV. Computational methods of analysis and recognition of pathological processes. Moscow: Medicine, 1978, 293 p. (in Russian).
20. 60 in anticancer therapy. Cancer Nanotechnol 2011; doi: 10, 1008/s 12645-011-0020.
21. Jiao F, Qu Y, Zhou G, et al. Modulation of oxidative stress by functionalized fullerene materials in the lung tissues of female C57/BL mice with a metastatic Lewis lung carcinoma. J Nanosci Nanotechnol. 2010; 10: 8632-7.22.
22. 60 fullerenes as anticancer agents in the therapy of malignant tumors. Patent of Ukraine for an invention No a201104882, April 14, 2011.